Enhancing Nrf2 activity in renal tubules through upregulating gene expression or drug therapy can ameliorate AKI, and targeting the Keap1–Nrf2 system can prevent the progression of kidney diseases [483]. The gene discussed is NFE2L2; the disease is kidney disorder.